ToolJoltTools

Clinical Trial Dosing Diary (Phase III)

Track self-reported dose times and adherence for a multi-site Phase III trial — scheduled dates, protocol windows and status, all offline in your browser. For subjects on oral therapy.

Plan and track self-reported dose times and adherence for a multi-site Phase III trial. Each row holds the subject ID, the visit/timepoint, the scheduled date, the protocol window (± days) and a status — so subjects on oral therapy can see at a glance what is due, what is in-window and what was missed. Runs entirely in your browser; no PHI leaves the device.

Use the protocol window (± days) to judge whether a visit is compliant. This is an operational planner — keep your validated EDC/eCRF as the system of record and export to CSV to reconcile.

No records yet. Add the first dose above — entries sort newest-first and the summary tracks completion and missed-window rates.
References: ICH E8(R1) general considerations for clinical studies; Note: not a medical device; not a substitute for a validated EDC.

For research / operational use only. Not a medical device and not a substitute for validated clinical systems or professional medical judgement. Verify against your trial protocol, IRB/ethics approval and applicable regulations (GCP, 21 CFR Part 11, HIPAA/GDPR).

Free clinical-trial dosing diary for a multi-site Phase III trial: track self-reported dose times and adherence with protocol windows and status — offline, PHI-private.

About Clinical Trial Dosing Diary (Phase III)

A free, offline clinical-trial operations tool for subjects on oral therapy. Plan and track self-reported dose times and adherence for a multi-site Phase III trial. Each row holds the subject ID, the visit/timepoint, the scheduled date, the protocol window (± days) and a status — so subjects on oral therapy can see at a glance what is due, what is in-window and what was missed. Runs entirely in your browser; no PHI leaves the device.

How to use Clinical Trial Dosing Diary (Phase III)

  1. 1Add each subject's dose with its scheduled date and the protocol window.
  2. 2Update the status (Scheduled, Window open, Completed, Missed, Out of window) as visits happen, recording deviations in the notes.
  3. 3Export to CSV to reconcile against your EDC, brief your monitor, or report completion and missed-window rates.

Why use Clinical Trial Dosing Diary (Phase III)?

  • Gives subjects on oral therapy a single, sortable view of self-reported dose times and adherence so nothing slips through the cracks between EDC updates.
  • Tracks scheduled dates against protocol windows (± days) and flags missed or out-of-window events — the metrics monitors review for a multi-site Phase III trial.
  • Privacy-first: subject IDs and notes stay in your browser only. No PHI is uploaded, which keeps the tool usable under your site's data-handling rules.

Frequently asked questions

What does this clinical-trial dosing diary do?+

It gives subjects on oral therapy a lightweight, offline way to plan and track self-reported dose times and adherence. Each entry records the subject ID, the visit or timepoint, the scheduled date, the allowed protocol window and a status, so the team can see what is due and catch missed or out-of-window events early — without waiting for an EDC report.

Is this a validated EDC or a medical device?+

No. It is an operational planning aid, not a 21 CFR Part 11-validated electronic data capture system and not a medical device. Keep your validated EDC/eCRF as the system of record; use this tool to organise day-to-day site operations and export to CSV to reconcile against the official data.

How are protocol windows handled?+

Each record stores the target date and a ± window in days. When a visit happens outside that window you mark it "Out of window", which the summary counts separately — exactly the compliance signal a monitor or sponsor looks at for a multi-site Phase III trial.

Is subject data kept private?+

Yes. All data lives in your browser via localStorage; nothing is sent to a server. To stay privacy-safe, use coded subject IDs (not names) — the tool is designed so identifiable PHI never has to be entered or transmitted.

Related tools

Related Lab & Research tools

Sponsored